Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1918-1919
Number of pages2
JournalMultiple Sclerosis Journal
Volume20
Issue number14
DOIs
Publication statusPublished - Dec 16 2014

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

@article{bf80fb6831f5446292cb37f932296396,
title = "Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?",
author = "Mario Rotondi and Roberto Bergamaschi and Luca Chiovato",
year = "2014",
month = "12",
day = "16",
doi = "10.1177/1352458514533387",
language = "English",
volume = "20",
pages = "1918--1919",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "14",

}

TY - JOUR

T1 - Disease modifying therapies in multiple sclerosis

T2 - Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?

AU - Rotondi, Mario

AU - Bergamaschi, Roberto

AU - Chiovato, Luca

PY - 2014/12/16

Y1 - 2014/12/16

UR - http://www.scopus.com/inward/record.url?scp=84924814760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924814760&partnerID=8YFLogxK

U2 - 10.1177/1352458514533387

DO - 10.1177/1352458514533387

M3 - Article

C2 - 24812044

AN - SCOPUS:84924814760

VL - 20

SP - 1918

EP - 1919

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 14

ER -